T&L Past Earnings Performance
Past criteria checks 4/6
T&L has been growing earnings at an average annual rate of 30.4%, while the Medical Equipment industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 26.5% per year. T&L's return on equity is 22.7%, and it has net margins of 25.8%.
Key information
30.4%
Earnings growth rate
26.4%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 26.5% |
| Return on equity | 22.7% |
| Net Margin | 25.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Do T&L's (KOSDAQ:340570) Earnings Warrant Your Attention?
Sep 23
T&L Co., Ltd.'s (KOSDAQ:340570) 26% Jump Shows Its Popularity With Investors
Aug 25Shareholders Would Enjoy A Repeat Of T&L's (KOSDAQ:340570) Recent Growth In Returns
Aug 12T&L Co., Ltd. (KOSDAQ:340570) Looks Just Right With A 28% Price Jump
Jul 05Are T&L Co., Ltd. (KOSDAQ:340570) Investors Paying Above The Intrinsic Value?
Jul 02T&L Co., Ltd. (KOSDAQ:340570) Not Flying Under The Radar
May 14Why We Like The Returns At T&L (KOSDAQ:340570)
Apr 09Is T&L Co., Ltd. (KOSDAQ:340570) Trading At A 33% Discount?
Mar 19T&L's (KOSDAQ:340570) Solid Earnings May Rest On Weak Foundations
Mar 25What Kind Of Investors Own Most Of T&L Co., Ltd. (KOSDAQ:340570)?
Feb 22Revenue & Expenses Breakdown
How T&L makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 131,617 | 33,963 | 11,119 | 3,326 |
| 31 Mar 24 | 113,233 | 26,679 | 10,221 | 3,456 |
| 31 Dec 23 | 115,461 | 27,439 | 9,551 | 3,432 |
| 30 Sep 23 | 116,228 | 29,825 | 8,229 | 2,822 |
| 30 Jun 23 | 106,663 | 27,672 | 7,388 | 2,659 |
| 31 Mar 23 | 93,828 | 24,779 | 6,780 | 2,577 |
| 31 Dec 22 | 81,577 | 21,118 | 6,373 | 2,468 |
| 30 Sep 22 | 81,192 | 21,723 | 5,590 | 2,433 |
| 30 Jun 22 | 79,005 | 22,387 | 5,384 | 2,317 |
| 31 Mar 22 | 72,099 | 20,274 | 5,051 | 2,205 |
| 31 Dec 21 | 71,896 | 19,585 | 5,088 | 2,274 |
| 30 Sep 21 | 63,257 | 17,158 | 4,416 | 2,205 |
| 30 Jun 21 | 53,601 | 14,675 | 4,030 | 2,097 |
| 31 Mar 21 | 46,383 | 11,651 | 3,964 | 1,969 |
| 31 Dec 20 | 40,633 | 10,042 | 3,610 | 1,961 |
| 30 Sep 20 | 36,014 | 9,540 | 3,386 | 1,640 |
| 30 Jun 20 | 36,456 | 7,820 | 3,443 | 1,794 |
| 31 Mar 20 | 34,212 | 7,499 | 3,282 | 1,803 |
| 31 Dec 19 | 32,623 | 7,286 | 3,119 | 1,631 |
| 31 Dec 18 | 26,331 | 4,658 | 3,072 | 1,839 |
Quality Earnings: A340570 has high quality earnings.
Growing Profit Margin: A340570's current net profit margins (25.8%) are lower than last year (25.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A340570's earnings have grown significantly by 30.4% per year over the past 5 years.
Accelerating Growth: A340570's earnings growth over the past year (22.7%) is below its 5-year average (30.4% per year).
Earnings vs Industry: A340570 earnings growth over the past year (22.7%) exceeded the Medical Equipment industry 1.6%.
Return on Equity
High ROE: A340570's Return on Equity (22.7%) is considered high.